XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Interim Condensed Consolidated Statements of Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
us-gaap_RevenuesAbstract    
Revenue $ 22,072 $ 26,262
Cost of revenues 2,503 3,508
Gross profit 19,569 22,754
Operating expenses:    
Research and development, net 17,991 18,674
Sales and marketing 2,816 2,719
General and administrative 3,572 3,827
Amortization of intangible assets 150 154
Total operating expenses 24,529 25,374
Operating income (loss) (4,960) (2,620)
Financial income, net 1,257 1,455
Remeasurement of marketable equity securities (60) (117)
Loss before taxes on income (3,763) (1,282)
Income tax expense 1,685 1,417
Net loss (5,448) (2,699)
Net loss from discontinued operation 0 (2,173)
Net loss $ (5,448) $ (4,872)
Basic and diluted (in dollars per share) $ (0.23) $ (0.12)
Basic and diluted net loss per share from discontinued operation (in dollars per share) 0 (0.09)
Basic and diluted net loss per share (in dollars per share) $ (0.23) $ (0.21)
us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract    
Basic and diluted (in shares) 23,508 23,334
License [Member]    
us-gaap_RevenuesAbstract    
Revenue $ 11,414 $ 18,248
Royalty [Member]    
us-gaap_RevenuesAbstract    
Revenue $ 10,658 $ 8,014